Financials data is unavailable for this security.
Cash flow in EURView more
In 2023, BBS-Bioactive Bone Substitutes Oyj increased its cash reserves by 29.93%, or 454.00k. Cash Flow from Financing totalled 3.38m or -- of revenues. In addition the company used 2.92m for operations while cash from investing was breakeven.
Cash flow per share | -0.2702 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2647 |
---|---|
Tangible book value per share | -0.134 |
More ▼
Balance sheet in EURView more
Current ratio | 1.47 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.9305 |
---|---|
Total debt/total capital | 0.482 |
More ▼